Picture of bioXXmed AG logo

T5O0 bioXXmed AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Cytotools secures financing to resume clinical development in Europe

Oct 30 (Reuters) - CYTOTOOLS AG  T5OG.DE : 
    * SECURES FINANCING TO RESUME CLINICAL DEVELOPMENT IN EUROPE 
    * SECURES FINANCING IN AMOUNT OF UP TO EUR 15 MILLION  
    * FIRST CONVERTIBLE BONDS OVER EUR 1 MILLION 
 
Source text for Eikon:  ID:nEQ2r1qlKa  
Further company coverage:  T5OG.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on bioXXmed AG

See all news